Small cell lung carcinoma (SCLC) cell lines expressing higher levels of STAT1 are more resistant to DOX, the chemotherapy agent etoposide (Etoposide), and radiotherapy [16]. This evidence concerns the gene STAT1 and small cell lung carcinoma.